Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2405 clinical trials
Featured trial
TOL2506A: A Phase 3, Single Arm, Open-Label Study Evaluating Ovarian Suppression Following Three-Month Leuprolide Acetate For Injectable Suspension (TOL2506) in Combination with Endocrine Therapy in Premenopausal Subjects with Hormone-Receptor–Positive (HR+), Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer

This is a phase 3, single arm, open-label study evaluating the effectiveness of TOL2506 to suppress ovarian function in premenopausal women with HR+, HER2-negative breast cancer. The study will

hormone therapy
anastrozole
letrozole
tamoxifen
erbb2
  • 0 views
  • 07 Jan, 2022
  • 1 location
Featured trial
Spectrum Neutropenia in Breast Cancer

Spectrum Neutropenia in Breast Cancer

  • 238 views
  • 08 Nov, 2020
  • 1 location
Featured trial
NON-INVASIVE CONFIRMATORY DETECTION OF BREAST CANCER (NICE-BC)

NON-INVASIVE CONFIRMATORY DETECTION OF BREAST CANCER (NICE-BC)

  • 558 views
  • 25 Mar, 2021
  • 1 location
Featured trial
SWOG S1202: A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer

SWOG S1202: A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer

  • 62 views
  • 08 Nov, 2020
  • 1 location
Featured trial
SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast

  • 148 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Featured trial
VastBiome: The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

The microbiome has the potential to serve as a robust biomarker of clinical response to immunotherapy. Additionally, microbial manipulation, through diet, exercise, prebiotics, probiotics, or microbially-derived metabolites, may prove to be beneficial in promoting anti-tumor immune responses. However, large prospective studies in humans with longitudinal sample collection and standardized methods …

targeted therapy
programmed cell death 1 ligand 1
cancer
cancer chemotherapy
  • 0 views
  • 28 Feb, 2022
  • 1 location
Breast Cancer Toxicity (CANTO)

The aims of the cohort will be to quantify impact of cancer treatments toxicities , and to generate predictors of chronic toxicity in patients with non-metastatic breast cancer. The

Accepts healthy volunteers
  • 0 views
  • 19 Apr, 2022
  • 1 location
Neoadjuvant Chemotherapy in Breast Cancer

This study compares two approaches of upfront chemotherapy in breast cancer.

  • 0 views
  • 28 Mar, 2021
  • 1 location